Fc gamma receptor I (FcγRI, CD64) is a well-known target antigen for passive immunotherapy against acute myeloid leukemia and chronic myelomonocytic leukemia. The gene discussed is FCGR1A; the disease is chronic myelomonocytic leukemia.